Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
Moodys
Express Scripts
Federal Trade Commission
US Army
Baxter
McKinsey
Healthtrust
Johnson and Johnson

Generated: February 25, 2018

DrugPatentWatch Database Preview

Liotrix (t4;t3) - Generic Drug Details

« Back to Dashboard

What are the generic sources for liotrix (t4;t3) and what is the scope of liotrix (t4;t3) patent protection?

Liotrix (t4;t3)
is the generic ingredient in ten branded drugs marketed by Parke Davis and Forest Labs, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.
Summary for liotrix (t4;t3)
US Patents:0
Tradenames:10
Applicants:2
NDAs:2
Suppliers / Packagers: 1
Drug Prices:see low prices
DailyMed Link:liotrix (t4;t3) at DailyMed
Pharmacology for liotrix (t4;t3)

US Patents and Regulatory Information for liotrix (t4;t3)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs THYROLAR-2 liotrix (t4;t3) TABLET;ORAL 016807-002 Approved Prior to Jan 1, 1982 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Forest Labs THYROLAR-0.5 liotrix (t4;t3) TABLET;ORAL 016807-005 Approved Prior to Jan 1, 1982 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis EUTHROID-2 liotrix (t4;t3) TABLET;ORAL 016680-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis EUTHROID-3 liotrix (t4;t3) TABLET;ORAL 016680-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Forest Labs THYROLAR-3 liotrix (t4;t3) TABLET;ORAL 016807-003 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis EUTHROID-1 liotrix (t4;t3) TABLET;ORAL 016680-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Forest Labs THYROLAR-1 liotrix (t4;t3) TABLET;ORAL 016807-004 Approved Prior to Jan 1, 1982 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Forest Labs THYROLAR-5 liotrix (t4;t3) TABLET;ORAL 016807-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Forest Labs THYROLAR-0.25 liotrix (t4;t3) TABLET;ORAL 016807-001 Approved Prior to Jan 1, 1982 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis EUTHROID-0.5 liotrix (t4;t3) TABLET;ORAL 016680-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Merck
Johnson and Johnson
Boehringer Ingelheim
Julphar
Covington
Federal Trade Commission
Moodys
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot